Intellia Therapeutics, Inc.
NTLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$101 | -$101 | -$114 | -$129 |
| Dep. & Amort. | $5 | $2 | $2 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $22 | $22 | $40 |
| Change in WC | $4 | -$20 | -$59 | $2 |
| Other Non-Cash | -$5 | -$3 | -$0 | -$1 |
| Operating Cash Flow | -$77 | -$100 | -$149 | -$85 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$117 | -$56 | -$83 | -$169 |
| Inv. Sales/Matur. | $116 | $163 | $178 | $322 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $107 | $94 | $152 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $115 | $13 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $0 | $2 |
| Financing Cash Flow | $115 | $15 | $0 | $2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $37 | $22 | -$55 | $69 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $170 | $148 | $203 | $134 |
| End Cash | $207 | $170 | $148 | $203 |
| Free Cash Flow | -$77 | -$100 | -$150 | -$86 |